Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 -0.05 (-4.95%)
At close: Aug 20, 2026 · 4:00 PM EDT

Lucid Diagnostics (LUCD) Total Debt (2021)

Lucid Diagnostics' (LUCD) quarterly Total Debt came in at $22.4 million in Q3 2021.

Lucid Diagnostics (LUCD) Total Debt (2021) Analysis & Trends

Lucid Diagnostics (LUCD) has 1 years of Total Debt data on file, last reported at $22.4 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 32.61 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 14.94 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.68 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 1.89 Bn
10 Lucid Diagnostics 175.80 Mn 142.40 Mn 55,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2021 22.40 Mn